Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model
Dow Jones Industrial Average
) is trading up 71 points (+0.5%) at 15,373 as of Thursday, May 30, 2013, 9:35 a.m. ET. During this time, 19.5 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 591.2 million. The NYSE advances/declines ratio sits at 1,446 issues advancing vs. 1,016 declining with 185 unchanged.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
The Dow component leading the way higher looks to be
), which is sporting a 22-cent gain (+0.5%) bringing the stock to $47.10. This single gain is lifting the Dow Jones Industrial Average by 1.67 points or roughly accounting for 2.4% of the Dow's overall gain. Volume for Merck currently sits at 495,722 shares traded vs. an average daily trading volume of 17.6 million shares.
Merck has a market cap of $143.79 billion and is part of the health care sector and drugs industry. Shares are up 16.3% year to date as of Wednesday's close. The stock's dividend yield sits at 3.6%.
Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide. The company has a P/E ratio of 24.3, above the S&P 500 P/E ratio of 17.7.
TheStreet Ratings rates Merck as a
. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income.
- You can view the full Merck Ratings Report.
Holding back the Dow today is
), which is lagging the broader Dow index with an 11-cent decline (-1.3%) bringing the stock to $8.47. Volume for Alcoa currently sits at 1.1 million shares traded vs. an average daily trading volume of 17.3 million shares.
Alcoa has a market cap of $9.19 billion and is part of the basic materials sector and metals & mining industry. Shares are down 1% year to date as of Wednesday's close. The stock's dividend yield sits at 1.4%.
Alcoa Inc. engages in the production and management of primary aluminum, fabricated aluminum, and alumina. The company operates in four segments: Alumina, Primary Metals, Global Rolled Products, and Engineered Products and Solutions. The company has a P/E ratio of 39, above the S&P 500 P/E ratio of 17.7.
TheStreet Ratings rates Alcoa as a
. The company's strengths can be seen in multiple areas, such as its increase in net income, good cash flow from operations and growth in earnings per share. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself.
- You can view the full Alcoa Ratings Report.
Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100% See his top picks for 14-days FREE